Cargando…

Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients

BACKGROUND: The COVID-19 outbreak has led to the rapid development and administration of the COVID-19 vaccines worldwide. Data about the immunogenicity and adverse effects of the vaccine on patients with systemic autoimmune rheumatic diseases (SARDs) is emerging. AIM: To evaluate Pfizer/BioNTech (BN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pri-Paz Basson, Yael, Tayer-Shifman, Oshrat E., Naser, Rawand, Tartakover Matalon, Shelly, Kimhi, Oded, Gepstein, Raz, Halperin, Tamar, Ziv-Baran, Tomer, Ziv, Amit, Parikh, Roma, Kivity, Shaye, Levy, Yair
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436715/ https://www.ncbi.nlm.nih.gov/pubmed/36050514 http://dx.doi.org/10.1007/s10067-022-06348-z

Ejemplares similares

Steroid treatment suppresses the CD4(+) T-cell response to the third dose of mRNA COVID-19 vaccine in systemic autoimmune rheumatic disease patients
por: Maliah, Avishai, et al.
Publicado: (2022)

Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment: Case series and literature review
por: Meridor, Katya, et al.
Publicado: (2021)

eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling
por: Attar-Schneider, Oshrat, et al.
Publicado: (2015)

Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination
por: Herishanu, Yair, et al.
Publicado: (2022)

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
por: Herishanu, Yair, et al.
Publicado: (2021)

Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia
por: Herishanu, Yair, et al.
Publicado: (2022)

Familial Mediterranean Fever and Hypercoagulability
por: Tayer-Shifman, Oshrat E., et al.
Publicado: (2011)

Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs
por: Agbarya, Abed, et al.
Publicado: (2021)

Clinical experience with biologic treatment in resistant eosinophilic fasciitis: Case reports and review of the literature
por: Erez, Daniel, et al.
Publicado: (2021)

SARS-CoV-2 Humoral and Cellular Immune Responses of Patients With HIV After Vaccination With BNT162b2 mRNA COVID-19 Vaccine in the Tel-Aviv Medical Center
por: Tau, Luba, et al.
Publicado: (2022)

Eosinophilic pneumonia following occupational smoke exposure
por: Peri, Yogev, et al.
Publicado: (2016)

Humoral and Cellular Immune Responses of People Living With Human Immunodeficiency Virus After 3 Doses of Messenger RNA BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine: A Prospective Cohort Study
por: Tau, Luba, et al.
Publicado: (2023)

Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments
por: Agbarya, Abed, et al.
Publicado: (2023)

β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
por: Zigmond, Ehud, et al.
Publicado: (2014)

Catastrophic antiphospholipid syndrome in lupus-associated immune thrombocytopenia treated with eltrombopag A case series and literature review
por: Garra, Wakar, et al.
Publicado: (2023)

A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients
por: Davidov, Yana, et al.
Publicado: (2022)

BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study
por: Rahav, Galia, et al.
Publicado: (2021)

αvβ3 Integrin as a Link between the Development of Fibrosis and Thyroid Hormones in Systemic Sclerosis
por: Kohon, Maia Yamila, et al.
Publicado: (2023)

Response to tozinameran (BNT162b2) booster in twice-vaccinated kidney transplant and maintenance dialysis patients
por: Ben-Dov, Iddo Z., et al.
Publicado: (2022)

Waning Immunity after the BNT162b2 Vaccine in Israel
por: Goldberg, Yair, et al.
Publicado: (2021)

MiRNAs in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension: Markers and Effectors
por: Zaaroor Levy, Mor, et al.
Publicado: (2022)

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
por: Levin, Einav G., et al.
Publicado: (2021)

Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel
por: Regev-Yochay, Gili, et al.
Publicado: (2021)

Comparison of a Telehealth-Based Intensive Treatment Program with a Rewarding App vs. On-Site Care for Youth with Obesity: A Historical Cohort Study
por: Sela Peremen, Khen, et al.
Publicado: (2023)

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel
por: Bar-On, Yinon M., et al.
Publicado: (2022)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

Routine statins use is associated with less adverse outcome in patients above 70 years of age admitted to hospital with COVID-19
por: Izkhakov, Elena, et al.
Publicado: (2023)

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
por: Bar-On, Yinon M., et al.
Publicado: (2021)

Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
por: Shashar, Moshe, et al.
Publicado: (2022)

The epidemiology of coronary artery bypass surgery in a community hospital: A comparison between 2 periods
por: Ziv-Baran, Tomer, et al.
Publicado: (2019)

Protection against Covid-19 by BNT162b2 Booster across Age Groups
por: Bar-On, Yinon M., et al.
Publicado: (2021)

Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial
por: Naftali, Timna, et al.
Publicado: (2021)

Biological Therapies in Inflammatory Myopathies
por: Natour, Abd El Haleem, et al.
Publicado: (2023)

Administration of BNT162b2 mRNA COVID-19 vaccine to subjects with various allergic backgrounds
por: Ribak, Yaarit, et al.
Publicado: (2023)

Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus
por: Sivakumaran, Jagan, et al.
Publicado: (2021)

Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment
por: Eliakim-Raz, Noa, et al.
Publicado: (2021)

Refractive Changes Induced by Strabismus Corrective Surgery in Adults
por: Mezad-Koursh, Daphna, et al.
Publicado: (2017)

Reduced hospitalization rates are not associated with increased mortality or readmission rates in an emergency department in Israel
por: Greenberg, Sharon A., et al.
Publicado: (2018)

A simple-to-use nomogram to predict long term survival of patients undergoing coronary artery bypass grafting (CABG) using bilateral internal thoracic artery grafting technique
por: Ziv-Baran, Tomer, et al.
Publicado: (2019)

Immunogenicity trends 1 and 3 months after second BNT162B2 vaccination among healthcare workers in Israel
por: Shachor-Meyouhas, Yael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l4atu30ejqjh24dfi935jium70